4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Trends in antimicrobial consumption in Bhutan

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Highlights

          • Overall consumption of antimicrobials in Bhutan is lower than most other countries.

          • A notable increase in overall consumption of antimicrobials in Bhutan was observed from 2017 to 2019 .

          • Wide variation in antimicrobial consumption was observed between dzongkhags (administrative districts).

          • The penicillin group of beta-lactam antibiotics were most commonly consumed in Bhutan.

          • The increase in consumption of broad-spectrum antimicrobials in Bhutan is of concern.

          Abstract

          Introduction

          Antimicrobial use has been recognized as one of the main drivers of antimicrobial resistanceand it is, therefore, crucial to monitor the consumption and use of antimicrobials. This study was conducted to determine the consumption of antimicrobials in terms of defined daily doses (DDDs) per 1000 inhabitants per day (DIDs) at both national and dzongkhag levels in Bhutan, and to investigate trends from 2017 to 2019.

          Methods

          A retrospective analysis of antimicrobial consumption in healthcare facilities in Bhutan from 2017 to 2019 was undertaken using the national records of annual distribution of medicines. World Health Organization Anatomical Therapeutic Chemical (ATC) Classification System/DDD methodology was used for data collection and analysis.

          Results

          In 2019, the consumption of antimicrobials (ATC subgroup J01) for systemic use in healthcare facilities in Bhutan was 16.29 DIDs, compared with 14.39 DIDs in 2018 and 13.27 DIDs in 2017. The most commonly used subgroup of antimicrobials was the penicillin group of beta-lactams (J01C).

          Conclusion

          Antimicrobial consumption in Bhutan was found to be lower than the European Union and European Economic Area average, and lower compared with most Eastern European countries and some countries in the Western Pacific region. However, overall consumption in Bhutan increased steadily over the 3-year study period. This should be monitored carefully, and appropriate interventions to optimize antimicrobial use should be put in place in the near future.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: not found

          Antimicrobial resistance: a global multifaceted phenomenon.

          Antimicrobial resistance (AMR) is one of the most serious global public health threats in this century. The first World Health Organization (WHO) Global report on surveillance of AMR, published in April 2014, collected for the first time data from national and international surveillance networks, showing the extent of this phenomenon in many parts of the world and also the presence of large gaps in the existing surveillance. In this review, we focus on antibacterial resistance (ABR), which represents at the moment the major problem, both for the high rates of resistance observed in bacteria that cause common infections and for the complexity of the consequences of ABR. We describe the health and economic impact of ABR, the principal risk factors for its emergence and, in particular, we illustrate the highlights of four antibiotic-resistant pathogens of global concern - Staphylococcus aureus, Klebsiella pneumoniae, non-typhoidal Salmonella and Mycobacterium tuberculosis - for whom we report resistance data worldwide. Measures to control the emergence and the spread of ABR are presented.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The global threat of antimicrobial resistance: science for intervention

            In the last decade we have witnessed a dramatic increase in the proportion and absolute number of bacterial pathogens resistant to multiple antibacterial agents. Multidrug-resistant bacteria are currently considered as an emergent global disease and a major public health problem. The B-Debate meeting brought together renowned experts representing the main stakeholders (i.e. policy makers, public health authorities, regulatory agencies, pharmaceutical companies and the scientific community at large) to review the global threat of antibiotic resistance and come up with a coordinated set of strategies to fight antimicrobial resistance in a multifaceted approach. We summarize the views of the B-Debate participants regarding the current situation of antimicrobial resistance in animals and the food chain, within the community and the healthcare setting as well as the role of the environment and the development of novel diagnostic and therapeutic strategies, providing expert recommendations to tackle the global threat of antimicrobial resistance.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Multidrug Resistant Acinetobacter

              Emergence and spread of Acinetobacter species, resistant to most of the available antimicrobial agents, is an area of great concern. It is now being frequently associated with healthcare associated infections. Literature was searched at PUBMED, Google Scholar, and Cochrane Library, using the terms ‘Acinetobacter Resistance, multidrug resistant (MDR), Antimicrobial Therapy, Outbreak, Colistin, Tigecycline, AmpC enzymes, and carbapenemases in various combinations. The terms such as MDR, Extensively Drug Resistant (XDR), and Pan Drug Resistant (PDR) have been used in published literature with varied definitions, leading to confusion in the correlation of data from various studies. In this review various mechanisms of resistance in the Acinetobacter species have been discussed. The review also probes upon the current therapeutic options, including combination therapies available to treat infections due to resistant Acinetobacter species in adults as well as children. There is an urgent need to enforce infection control measures and antimicrobial stewardship programs to prevent the further spread of these resistant Acinetobacter species and to delay the emergence of increased resistance in the bacteria.
                Bookmark

                Author and article information

                Contributors
                Journal
                IJID Reg
                IJID Reg
                IJID Regions
                Elsevier
                2772-7076
                02 October 2021
                December 2021
                02 October 2021
                : 1
                : 65-71
                Affiliations
                [a ]Department of Pharmacy, Jigme Dorji Wangchuk National Referral Hospital , Thimphu, Bhutan
                [b ]Department of Medical Services, Ministry of Health, Thimphu, Bhutan
                [c ]National Centre for Antimicrobial Stewardship, Royal Melbourne Hospital, Melbourne, Australia
                Author notes
                [* ]Corresponding author. Address: Department of Pharmacy, JDWNR Hospital, Menkhang Lam, Thimphu, Bhutan. thuptent@ 123456jdwnrh.gov.bt
                Article
                S2772-7076(21)00012-6
                10.1016/j.ijregi.2021.09.009
                9216644
                35757828
                924640c1-88c8-41a6-bbd7-f8a617eb26b1
                Crown Copyright © 2021 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 28 July 2021
                : 9 September 2021
                : 26 September 2021
                Categories
                Original Report

                antimicrobial consumption,antimicrobial resistance,defined daily dose,trends,surveillance,broad-sepectrum antibiotic

                Comments

                Comment on this article